Evaluation of the antipsychotic medication review process at four long-term facilities in Alberta

Arden Birney,1 Paola Charland,1 Mollie Cole,2 Mubashir Aslam Arain1 1Workforce Research & Evaluation, 2Seniors Health Strategic Clinical Network, Alberta Health Services, Calgary, AB, Canada Purpose: The goal of this evaluation was to understand how four long-term care (LTC) ­facilit...

Full description

Bibliographic Details
Main Authors: Birney A, Charland P, Cole M, Aslam Arain M
Format: Article
Language:English
Published: Dove Medical Press 2016-10-01
Series:Journal of Multidisciplinary Healthcare
Subjects:
Online Access:https://www.dovepress.com/evaluation-of-the-antipsychotic-medication-review-process-at-four-long-peer-reviewed-article-JMDH
id doaj-697489b21e2c46269892985f40697c18
record_format Article
spelling doaj-697489b21e2c46269892985f40697c182020-11-24T22:19:28ZengDove Medical PressJournal of Multidisciplinary Healthcare1178-23902016-10-01Volume 949950929259Evaluation of the antipsychotic medication review process at four long-term facilities in AlbertaBirney ACharland PCole MAslam Arain MArden Birney,1 Paola Charland,1 Mollie Cole,2 Mubashir Aslam Arain1 1Workforce Research & Evaluation, 2Seniors Health Strategic Clinical Network, Alberta Health Services, Calgary, AB, Canada Purpose: The goal of this evaluation was to understand how four long-term care (LTC) ­facilities in Alberta have implemented medication reviews for the Appropriate Use of Antipsychotics (AUA) initiative. We aimed to determine how interprofessional (IP) collaboration was incorporated in the antipsychotic medication reviews and how the reviews had been sustained.Methods: Four LTC facilities in Alberta participated in this evaluation. We conducted semistructured interviews with 18 facility staff and observed one antipsychotic medication review at each facility. We analyzed data according to the following key components that we identified as relevant to the antipsychotic medication reviews: the structure of the reviews, IP interactions between the staff members, and strategies for sustaining the reviews.Results: The duration of antipsychotic medication reviews ranged from 1 to 1.5 hours. The number of professions in attendance ranged from 3 to 9; a pharmacist led the review at two sites, while a registered nurse led the review at one site and a nurse practitioner at the remaining site. The number of residents discussed during the review ranged from 6 to 20. The process at some facilities was highly IP, demonstrating each of the six IP competencies. Other facilities conducted the review in a less IP manner due to challenges of physician involvement and staff workload, particularly of health care aides. Facilities that had a nurse practitioner on site were more efficient with the process of implementing recommendations resulting from the medication reviews.Conclusion: The LTC facilities were successful in implementing the medication review process and the process seemed to be sustainable. A few challenges were observed in the implementation process at two facilities. IP practice moved forward the goals of the AUA initiative to reduce the inappropriate use of antipsychotics. Keywords: interprofessional, antipsychotic, senior, medication review, evaluationhttps://www.dovepress.com/evaluation-of-the-antipsychotic-medication-review-process-at-four-long-peer-reviewed-article-JMDHinterprofessionalantipsychoticseniormedication reviewevaluation
collection DOAJ
language English
format Article
sources DOAJ
author Birney A
Charland P
Cole M
Aslam Arain M
spellingShingle Birney A
Charland P
Cole M
Aslam Arain M
Evaluation of the antipsychotic medication review process at four long-term facilities in Alberta
Journal of Multidisciplinary Healthcare
interprofessional
antipsychotic
senior
medication review
evaluation
author_facet Birney A
Charland P
Cole M
Aslam Arain M
author_sort Birney A
title Evaluation of the antipsychotic medication review process at four long-term facilities in Alberta
title_short Evaluation of the antipsychotic medication review process at four long-term facilities in Alberta
title_full Evaluation of the antipsychotic medication review process at four long-term facilities in Alberta
title_fullStr Evaluation of the antipsychotic medication review process at four long-term facilities in Alberta
title_full_unstemmed Evaluation of the antipsychotic medication review process at four long-term facilities in Alberta
title_sort evaluation of the antipsychotic medication review process at four long-term facilities in alberta
publisher Dove Medical Press
series Journal of Multidisciplinary Healthcare
issn 1178-2390
publishDate 2016-10-01
description Arden Birney,1 Paola Charland,1 Mollie Cole,2 Mubashir Aslam Arain1 1Workforce Research & Evaluation, 2Seniors Health Strategic Clinical Network, Alberta Health Services, Calgary, AB, Canada Purpose: The goal of this evaluation was to understand how four long-term care (LTC) ­facilities in Alberta have implemented medication reviews for the Appropriate Use of Antipsychotics (AUA) initiative. We aimed to determine how interprofessional (IP) collaboration was incorporated in the antipsychotic medication reviews and how the reviews had been sustained.Methods: Four LTC facilities in Alberta participated in this evaluation. We conducted semistructured interviews with 18 facility staff and observed one antipsychotic medication review at each facility. We analyzed data according to the following key components that we identified as relevant to the antipsychotic medication reviews: the structure of the reviews, IP interactions between the staff members, and strategies for sustaining the reviews.Results: The duration of antipsychotic medication reviews ranged from 1 to 1.5 hours. The number of professions in attendance ranged from 3 to 9; a pharmacist led the review at two sites, while a registered nurse led the review at one site and a nurse practitioner at the remaining site. The number of residents discussed during the review ranged from 6 to 20. The process at some facilities was highly IP, demonstrating each of the six IP competencies. Other facilities conducted the review in a less IP manner due to challenges of physician involvement and staff workload, particularly of health care aides. Facilities that had a nurse practitioner on site were more efficient with the process of implementing recommendations resulting from the medication reviews.Conclusion: The LTC facilities were successful in implementing the medication review process and the process seemed to be sustainable. A few challenges were observed in the implementation process at two facilities. IP practice moved forward the goals of the AUA initiative to reduce the inappropriate use of antipsychotics. Keywords: interprofessional, antipsychotic, senior, medication review, evaluation
topic interprofessional
antipsychotic
senior
medication review
evaluation
url https://www.dovepress.com/evaluation-of-the-antipsychotic-medication-review-process-at-four-long-peer-reviewed-article-JMDH
work_keys_str_mv AT birneya evaluationoftheantipsychoticmedicationreviewprocessatfourlongtermfacilitiesinalberta
AT charlandp evaluationoftheantipsychoticmedicationreviewprocessatfourlongtermfacilitiesinalberta
AT colem evaluationoftheantipsychoticmedicationreviewprocessatfourlongtermfacilitiesinalberta
AT aslamarainm evaluationoftheantipsychoticmedicationreviewprocessatfourlongtermfacilitiesinalberta
_version_ 1725779038420598784